Dosage Protocols
No FDA-approved dosing guidelines exist for CJC-1295. The following protocols are derived from clinical research and community reports.
CJC-1295 without DAC (Mod GRF 1-29)
- Conservative starting dose: 50–100 mcg per injection
- Standard dose: 100–200 mcg per injection
- Frequency: 1–2 times daily (bedtime dose is considered most important)
- Timing: Often administered before bed to coincide with natural GH release, and/or upon waking
- Cycle length: 8–12 weeks, followed by 4 weeks off
CJC-1295 with DAC
- Starting dose: 300 mcg per injection twice weekly
- Maintenance dose: 300–600 mcg once or twice weekly
- Cycle length: 8–12 weeks
Cycling Guidelines
Most practitioners recommend cycling CJC-1295 to prevent receptor desensitization and maintain the body's responsiveness to the peptide. A common approach involves 8–12 weeks on, followed by 4–8 weeks off. Some users employ a 5 days on, 2 days off weekly schedule with the non-DAC version to preserve pulsatile release patterns.